Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection Fraction

BACKGROUND: Recent evidence suggests that the mineralocorticoid receptor antagonist spironolactone should be the preferred fourth-line antihypertensive treatment in resistant hypertension (RHTN). Whether spironolactone improves blood pressure (BP) control in heart failure with preserved ejection fra...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Am J Hypertens
Main Authors: Rossignol, Patrick, Claggett, Brian Lee, Liu, Jiankang, Vardeny, Orly, Pitt, Bertram, Zannad, Faiez, Solomon, Scott
Formáid: Artigo
Teanga:Inglês
Foilsithe: Oxford University Press 2018
Ábhair:
Original Contributions
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5861580/
https://ncbi.nlm.nih.gov/pubmed/29228101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajh/hpx210
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla